0000000000227290

AUTHOR

Ana María González-pinto

0000-0002-2568-5179

showing 6 related works from this author

Gene-environment interaction as a predictor of early adjustment in first episode psychosis.

2017

Abstract Background This study aims to explore the gene-environment interaction hypothesis applied to pre-symptomatic neurodevelopmental phenotypes of first episode psychosis (FEP), that is, genetic factors might increase vulnerability to the effects of environmental adverse conditions occurring at later stages of development. Methods We constructed a schematic ‘two-hit’ model, with Val/Val homozygosity for the catechol- O -methyltransferase ( COMT ) Val158Met polymorphism as the ‘first hit’ and history of obstetric complications and parental socioeconomic status as ‘second hits’. Early adjustment, measured using the Premorbid Adjustment Scale, was considered the main outcome. The study pop…

AdultMaleParentsmedicine.medical_specialtyGenotypePremorbid Adjustment ScaleCatechol O-MethyltransferasePolymorphism Single NucleotideStatistics Nonparametric03 medical and health sciencesYoung Adult0302 clinical medicineMethioninePolymorphism (computer science)First episode psychosismedicineHumansGenetic Predisposition to DiseaseGene–environment interactionPsychiatrySocioeconomic statusBiological PsychiatryRetrospective StudiesAdverse conditionsValinemedicine.disease030227 psychiatryPsychiatry and Mental healthPsychotic DisordersSchizophreniaPopulation studyFemaleGene-Environment InteractionPsychology030217 neurology & neurosurgeryDemographySchizophrenia research
researchProduct

Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.

2014

Recently, Functional Remediation (FR) has proven to be effective in improving the functional outcome of euthymic bipolar patients. The aim of this study was to test the efficacy of the FR program in a subsample of euthymic bipolar II patients (BPII). A post-hoc analyses were undertaken using data of 53 BPII outpatients who had participated in a multicenter, rater-blind, randomized, controlled trial exploring the efficacy of FR (n=17) as compared with a Psychoeducation group (PSY) (n=19) and a treatment as usual control group (TAU n=17). The primary outcome variable was the functional improvement defined as the mean change in the Functioning Assessment Short Test (FAST) from baseline to endp…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentlaw.inventionBipolar II disorderCognitionRandomized controlled triallawInternal medicinePsychoeducationmedicineHumansPharmacology (medical)Single-Blind MethodBipolar disorderBiological PsychiatryPharmacologyPsychiatric Status Rating ScalesCognitive Behavioral Therapymedicine.diseaseCognitive behavioral therapyPsychiatry and Mental healthTreatment OutcomeNeurologyCognitive remediation therapyFemaleNeurology (clinical)medicine.symptomPsychologyNeurocognitiveManiaClinical psychologyEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.

2018

Background: Hyperprolactinemia is a common side-effect of antipsychotics (APs), which may trigger serious secondary problems and compromise the adherence to treatment which is crucial for prognosis, especially in patients presenting with a first-episode of psychosis (FEP). Aims: We evaluated, in some cases for the first time, the effect of polymorphisms in multiple candidate genes on serum prolactin (PRL) levels in an AP-treated FEP cohort recruited in the multicenter PEPs study (Phenotype − genotype and environmental interaction; Application of a predictive model in first psychotic episodes). Methods: PRL concentration was measured in serum from 222 patients. A total of 167 polymorphisms w…

AdultMalePsychosismedicine.medical_specialtyCandidate geneSerotoninSide effectAdolescentmedicine.medical_treatmentDopaminePeptidyl-Dipeptidase A03 medical and health sciencesYoung Adult0302 clinical medicineDopaminePolymorphism (computer science)Internal medicinemedicineHumansReceptor trkBPharmacology (medical)AntipsychoticPharmacologyMembrane GlycoproteinsPolymorphism Geneticbusiness.industryReceptors Dopamine D2medicine.diseaseProlactin030227 psychiatryProlactinHyperprolactinemiaPsychiatry and Mental healthEndocrinologyPsychotic DisordersCohortFemalebusiness030217 neurology & neurosurgerymedicine.drugAntipsychotic AgentsJournal of psychopharmacology (Oxford, England)
researchProduct

Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables.

2018

Objective: The current investigation aimed at studying the sociodemographic, clinical, and neuropsychological variables related to functional outcome in a sample of euthymic patients with bipolar disorder(BD) presenting moderate-severe levels of functional impairment. Methods: Two-hundred and thirty-nine participants with BD disorders and with Functioning Assessment Short Test(FAST) scores equal or above 18 were administered a clinical and diagnostic interview, and the administration of mood measure scales and a comprehensive neuropsychological battery. Analyses involved preliminary Pearson bivariate correlations to identify sociodemographic and clinical variables associated with the FAST t…

AdultMaleBipolar DisorderneurocognitionNeurocognitive DisordersBivariate analysisNeuropsychological TestsSpeech Disorders03 medical and health sciencesdepressive symptoms0302 clinical medicineRating scalemedicineVerbal fluency testHumansBipolar disorderbipolar disorderbusiness.industryNeuropsychologyMiddle Agedmedicine.diseaseCyclothymic Disorder030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthfunctional impairmentMoodMemory Short-TermSpainFemaleVerbal memorybusinessNeurocognitive030217 neurology & neurosurgeryClinical psychologyActa psychiatrica Scandinavica
researchProduct

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

2016

BackgroundFunctional remediation is a novel intervention with demonstrated efficacy at improving functional outcome in euthymic bipolar patients. However, in a previous trial no significant changes in neurocognitive measures were detected. The objective of the present analysis was to test the efficacy of this therapy in the enhancement of neuropsychological functions in a subgroup of neurocognitively impaired bipolar patients.MethodA total of 188 out of 239 DSM-IV euthymic bipolar patients performing below two standard deviations from the mean of normative data in any neurocognitive test were included in this subanalysis. Repeated-measures analyses of variance were conducted to assess the i…

AdultMalemedicine.medical_specialtyBipolar DisorderCognition disordersmedicine.medical_treatmenteducation.educational_degreePsychiatric rehabilitationRehabilitació de drogoaddictesNeuropsychological TestsPsychiatric RehabilitationAudiologyVerbal learningTrastorns de la cognició03 medical and health sciences0302 clinical medicinePatient Education as TopicMemorymedicinePsychoeducationHumansManic-depressive illnessBipolar disordereducationApplied PsychologyTrastorn bipolarNeuropsychologyMiddle AgedVerbal Learningmedicine.disease030227 psychiatryPsychiatry and Mental healthNarcotics addicts rehabilitationSchizophreniaMental RecallFemaleVerbal memoryCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryClinical psychology
researchProduct

Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

2016

We analyzed the efficacy of functional remediation, in a sample of patients with bipolar disorder who presented with subsyndromal symptoms. From a total sample of 239 patients with bipolar I and II disorder, according to DSM-IV-TR diagnostic criteria, entering a randomized clinical trial, those patients who presented with subsyndromal symptoms were selected based on a method already described by Berk and colleagues was applied. It consists of using the Clinical Global Impression-Bipolar version (CGI-BP) to establish the scores of the Hamilton Depression Rating Scale (HAM-D) and of the Young Mania Rating Scale (YMRS) that correspond with 1 in the CGI-BP. Functional outcome and mood symptoms …

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentYoung Mania Rating Scalelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawmental disordersmedicinePsychoeducationHumansPharmacology (medical)Bipolar disorderBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesPharmacologyAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseCognitive Remediation030227 psychiatryPsychotherapyPsychiatry and Mental healthTreatment OutcomeMoodNeurologyPhysical therapyFemaleNeurology (clinical)PsychologyPsychosocial030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyEuropean Neuropsychopharmacology
researchProduct